510(k) Report

510(k) · Cleared

Cleared

Surgisis Ocular Graft

K053622510(k) TraditionalCleared Mar 15, 200677-day reviewClass II21 CFR 886.3130

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Iop, Inc. · NXM Prosthesis, Eyelid Spacer/Graft, Biologic

Cleared on Mar 15, 2006 as substantially equivalent to K980431 (Cook Biotech, Inc., 1998) and 3 other predicates after a 77-day review. Its family tree reaches back 5 generations to 1992. 2 later devices descend from it.

Decided
Mar 15, 2006
Review
77 days
Class
Class II
Product code
NXM
Recalls
None
Predicates
4

Its longest line of descent runs back 5 generations to K921895 (1992). 18 ancestors in all, the oldest K830889 (1983). 2 later devices descend from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2003: 1 other ancestor2002: 1 other ancestor2000: 4 other ancestors1997: 3 other ancestors1992: 2 other ancestors1983: 1 other ancestor2001: 1 other ancestor2009: 1 descendant cleared2023: 1 descendant clearedK921895 · Tissue Patch, Tissue Graft · Bio-Vascular, Inc. · 1992K961810 · Supple Peri-Guard Pericardium · Bio-Vascular, Inc. · 1996K980431 · Surgisis · Cook Biotech, Inc. · 1998K034039 · Sis Plastic Surgery Matrix · Cook Biotech, Inc. · 2004K050246 · Sis Dermal Augmentation Strand · Cook Biotech, Inc. · 200519801990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor2 generations back: 5 other ancestors3 generations back: 7 other ancestors 1 generation forward: 1 descendant2 generations forward: 1 descendant K050246 · Sis Dermal Augmentation Strand · Cook Biotech, Inc. · 2005K034039 · Sis Plastic Surgery Matrix · Cook Biotech, Inc. · 2004K980431 · Surgisis · Cook Biotech, Inc. · 1998K961810 · Supple Peri-Guard Pericardium · Bio-Vascular, Inc. · 1996K921895 · Tissue Patch, Tissue Graft · Bio-Vascular, Inc. · 1992−50
  1. Root · 5 generations backK921895 Tissue Patch, Tissue GraftBio-Vascular, Inc. · 1992
  2. 4 generations backK961810 Supple Peri-Guard PericardiumBio-Vascular, Inc. · 1996
  3. 3 generations backK980431 SurgisisCook Biotech, Inc. · 1998
  4. 2 generations backK034039 Sis Plastic Surgery MatrixCook Biotech, Inc. · 2004
  5. 1 generation backK050246 Sis Dermal Augmentation StrandCook Biotech, Inc. · 2005
  6. This deviceK053622 Surgisis Ocular GraftIop, Inc. · 2006
  7. Descendant · cites it directly · 1 of its ownK090078 Kerasys Bioengineered Lamellar Patch GraftIop, Inc. · 2009
  8. Descendant · 2 generations on · 0 of its ownK223074 CorNeat EverPatchCorneat Vision, Ltd. · 2023 · Recalled

Most influential descendants

Showing 2 of 2 · See all
  • K090078Kerasys Bioengineered Lamellar Patch GraftIop, Inc. · 2009 · cites it directly1descendant
  • K223074CorNeat EverPatchCorneat Vision, Ltd. · 2023 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K921895Tissue Patch, Tissue GraftBio-Vascular, Inc.1992—
−4K961810Supple Peri-Guard PericardiumBio-Vascular, Inc.1996—
−3K980431SurgisisCook Biotech, Inc.1998—
−2K034039Sis Plastic Surgery MatrixCook Biotech, Inc.2004—
−1K050246Sis Dermal Augmentation StrandCook Biotech, Inc.2005—
0 (this device)K053622Surgisis Ocular GraftIop, Inc.2006—
+1K090078Kerasys Bioengineered Lamellar Patch GraftIop, Inc.2009—
+2K223074CorNeat EverPatchCorneat Vision, Ltd.20233

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198310
199220
199730
200040
200110
200210
200310

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200910
202310
FIG. 1 — Lineage of K053622, 1992–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NXM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K980431Surgisis
Summary page 2
…SIS Plastic Surgery Matrix Amniotic Membrane SIS Facial Implant 510(k) Applied For K980431 K03210)4 K034039…
Cook Biotech, Inc.1998—
*K034039Sis Plastic Surgery Matrix
Summary page 2
…SIS Facial Implant 510(k) Applied For K980431 K03210)4 K034039 K050246 Product Specifications Material Processed porcine Processed…
Cook Biotech, Inc.2004—
*K050246Sis Dermal Augmentation Strand
Summary page 2
…) Applied For K980431 K03210)4 K034039 K050246 Product Specifications Material Processed porcine Processed porcine IAmniotic Membrane with ophthal…
Cook Biotech, Inc.2005—
*K032104AmniolensBio-Tissue, Inc.20033

Also cleared against K980431: 28 other devices →

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K090078Kerasys Bioengineered Lamellar Patch GraftIop, Inc.20091

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 14 years and passes through 3 companies; a new generation was cleared every 2.0 years on median.
  • 1 of the 18 ancestors has a recall of any class.
  • Of its descendants, K090078 (Iop, Inc., 2009) has gone furthest, with 1 descendant of its own.
  • 28 other devices also cite its predicate K980431.

How does its category compare?

All NXM devices

NXM Prosthesis, Eyelid Spacer/Graft, Biologic: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · NXM

1in 2009

2009: 1
2007high 1 (2009) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NXM

Too few NXM 510(k)s in any year since 2007 to give a median.

Recalls per year · NXM

No recall names NXM since 2007.

Adverse event reports per year · NXM

1in 2015

2015: 1
2007high 1 (2015) · low 0 (2007)2025

MAUDE reports naming product code NXM, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20091—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—01
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The SURGISIS Ocular Graft is intended for implantation to reinforce and aid reconstruction of the eyelid and is labeled for single use.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K053622: Surgisis Ocular Graft.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K053622

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026